Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1508866 | 0.77 | TSHR (0.33) | TSHRCRBN | |
| SCHEMBL1508897 | 0.77 | TSHR (0.33) | TSHRCRBN | |
| SCHEMBL14626896 | 0.68 | — | — | |
| SCHEMBL10942401 | 0.67 | LMNA (0.33) | SMN1; SMN2 | |
| SCHEMBL31565143 | 0.67 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL15835009 | 0.65 | SMN1; SMN2 (0.31) | SMN1; SMN2TSHRCRBN | |
| SCHEMBL4231371 | 0.65 | — | — | |
| SCHEMBL4231375 | 0.65 | — | — | |
| SCHEMBL2598217 | 0.64 | CHRNB2 (0.33) | CRBN | |
| SCHEMBL15007138 | 0.64 | CHRNB2 (0.33) | CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250043353-A1 | BIOMARKERS OF RESPONSE TO SELECTIVE INHIBITORS OF AURORA A KINASE | MILLENNIUM PHARM INC (US) | 2025-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250043353-A1 | BIOMARKERS OF RESPONSE TO SELECTIVE INHIBITORS OF AURORA A KINASE | WNT1, XPOT, CTNNBL1 | SMN1; SMN2 4123/4885TSHR 4432/4885CRBN 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.